全体要約
2023年のグローバルな抗体受託製造市場の規模は、数百万米ドルと評価されており、2030年までに市場規模が再調整される見込みです。この期間中の年平均成長率（CAGR）は未定ですが、安定した成長が期待されています。市場の成長には、製品の差別化、コスト削減、サプライチェーンの最適化が重要です。
抗体受託製造市場は、モノクローナル抗体、抗体断片、ポリクローナル抗体などのタイプに分かれ、アメリカ、アジア太平洋、ヨーロッパ、中東・アフリカの地域別に分析されています。市場の推進要因には、政府の規制、環境問題、技術革新、消費者の嗜好の変化が含まれます。競争環境では、主要企業のプロファイルや市場シェア、戦略が分析されています。
関連する質問
AMRI, AGC Biologics, Aldevron, Eurofins CDMO, Boehringer Ingelheim BioXcellence, FUJIFILM Diosynth Biotechnologies, Emergent BioSolutions, KBI Biopharma, Lonza, Novasep, Nitto Avecia Pharma Services, Pierre Fabre, Samsung BioLogics, Synthon, Thermo Fisher Scientific
製品の差別化, コスト削減, サプライチェーンの最適化
概要
この研究報告は、世界の抗体受託製造市場の成長可能性を強調しています。抗体受託製造は、将来の市場で安定した成長を示すと期待されています。しかし、製品の差別化、コスト削減、サプライチェーンの最適化は、抗体受託製造の広範な採用にとって重要な要素となります。市場プレイヤーは、研究開発に投資し、戦略的パートナーシップを築き、進化する消費者の嗜好に沿った提供を行う必要があります。これらは、抗体受託製造市場が示す巨大な機会を活用するために欠かせません。
主な機能：
抗体受託製造市場に関する報告書は、さまざまな側面を反映し、業界に貴重な洞察を提供。
市場規模と成長：この研究報告書は、抗体受託製造市場の現在の規模と成長の概要を提供します。これには、歴史的データ、タイプ別の市場セグメンテーション（例：モノクローナル抗体、抗体断片）、および地域別の内訳が含まれる場合があります。
市場の推進要因と課題：この報告書では、抗体受託製造市場の成長を促進する要因（政府の規制、環境問題、技術の進歩、消費者の嗜好の変化など）を特定し分析することができます。また、インフラの制約、航続距離への不安、高い初期費用など、業界が直面する課題についても言及することができます。
競争環境：この調査報告書では、抗体受託製造市場における競争環境の分析が提供されています。主要なプレーヤーのプロファイル、市場シェア、戦略、および製品提供が含まれています。また、報告書は新興プレーヤーやそれらが市場に与える潜在的な影響も強調することができます。
技術の進展: 研究報告書は、抗体受託製造業界における最新の技術的進展について詳しく調査することができます。これには、抗体受託製造技術の進歩、抗体受託製造の新規参入者、抗体受託製造の新規投資、および抗体受託製造の未来を形作るその他の革新が含まれます。
下流の顧客の好み：この報告書は、抗体契約製造市場における顧客の行動や採用傾向を明らかにすることができます。顧客の購入決定に影響を与える要因や、抗体契約製造製品に対する好みが含まれています。
政府の政策とインセンティブ：研究報告書では、抗体受託製造市場に対する政府の政策とインセンティブの影響を分析しています。これには、規制の枠組み、補助金、税制優遇措置、及び抗体受託製造市場の促進を目的としたその他の措置の評価が含まれる可能性があります。また、報告書では、これらの政策が市場の成長を促進する上での効果を評価しています。
環境影響と持続可能性：この研究報告書は、抗体受託製造市場の環境影響と持続可能性の側面を評価しています。
市場予測と将来の見通し：分析に基づいて、研究報告書は抗体受託製造業界の市場予測と見通しを提供します。これには、市場規模、成長率、地域動向、技術の進歩や政策の動向に関する予測が含まれます。
推奨と機会：報告書は、業界の関係者、政策立案者、投資家への推奨で締めくくられています。新たなトレンドを活かし、課題を克服し、抗体受託製造市場の成長と発展に貢献するための市場参加者にとっての潜在的な機会が強調されています。
市場のセグメンテーション:
抗体受託製造市場は、タイプ別およびアプリケーション別に分かれています。2019年から2030年の期間において、セグメント間の成長は、タイプ別およびアプリケーション別に消費価値の正確な計算と予測を提供します。
タイプ別セグメンテーション
モノクローナル抗体
抗体断片
ポリクローナル抗体
アプリケーション別のセグメンテーション
中小企業
大企業
このレポートでは、市場を地域ごとに分割しています：
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下にプロフィールが掲載されている企業は、主要な専門家からの意見を集め、企業のカバレッジ、製品ポートフォリオ、市場浸透の分析に基づいて選ばれました。
AMRI
AGCバイオロジクス
アルデブロン
ユーロフィン・CDMO
バイオエクセレンス ボーリンガー・インゲルハイム
富士フイルムディオシンビオテクノロジーズ
エマージェント・バイオソリューションズ
KBIバイオファーマ
ロンザ
ノバセップ
ニットーアベイシアファーマサービス
ピエール・ファーブル
サムスンバイオロジクス
シンソン
サーモフィッシャーサイエンティフィック
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの抗体受託製造市場規模、（2019年～2030年）
2.1.2 抗体受託製造市場規模、CAGR（地域別）（2019年 vs 2023年 vs 2030年）
2.2 抗体受託製造セグメント、タイプ別
2.2.1 モノクローナル抗体
2.2.2 抗体断片
2.2.3 ポリクローナル抗体
2.3 抗体受託製造市場規模：タイプ別
2.3.1 抗体受託製造市場規模、CAGR（タイプ別）（2019年 vs 2023年 vs 2030年）
2.3.2 グローバルの抗体受託製造市場規模、市場シェア（タイプ別）（2019年～2024年）
2.4 抗体受託製造セグメント、用途別
2.4.1 中小企業
2.4.2 大企業
2.5 抗体受託製造市場規模：用途別
2.5.1 抗体受託製造市場規模、CAGR（用途別）（2019年 vs 2023年 vs 2030年）
2.5.2 グローバルの抗体受託製造市場規模、市場シェア（用途別）（2019年～2024年）
3 抗体受託製造市場規模：プレイヤー別
3.1 抗体受託製造市場規模、市場シェア（プレイヤー別）
3.1.1 グローバルにおける抗体受託製造市場の収益規模、プレイヤー別（2019年～2024年）
3.1.2 グローバルにおける抗体受託製造市場の収益シェア、プレイヤー別（2019年～2024年）
3.2 グローバルの抗体受託製造市場キープレイヤー拠点および提供製品
3.3 市場集中度分析
3.3.1 競合情勢分析
3.3.2 集中度レシオ（CR3、CR5、CR10）（2022年～2024年）
3.4 新製品・潜在的参入
3.5 M&A、拡大
4 抗体受託製造、地域別
4.1 抗体受託製造市場規模（地域別）（2019年～2024年）
4.2 アメリカズにおける抗体受託製造市場規模成長（2019年〜2024年）
4.3 APACにおける抗体受託製造市場規模成長（2019年〜2024年）
4.4 ヨーロッパにおける抗体受託製造市場規模成長（2019年〜2024年）
4.5 中東・アフリカにおける抗体受託製造市場規模成長（2019年〜2024年）
5 アメリカズ
5.1 アメリカズにおける抗体受託製造市場規模、国別（2019年〜2024年）
5.2 アメリカズにおける抗体受託製造市場規模、タイプ別（2019年〜2024年）
5.3 アメリカズにおける抗体受託製造市場規模、用途別（2019年〜2024年）
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける抗体受託製造市場規模、地域別（2019年〜2024年）
6.2 APACにおける抗体受託製造市場規模、タイプ別（2019年〜2024年）
6.3 APACにおける抗体受託製造市場規模、用途別（2019年〜2024年）
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
7 ヨーロッパ
7.1 ヨーロッパの抗体受託製造 国別（2019年～2024年）
7.2 ヨーロッパにおける抗体受託製造市場規模、タイプ別（2019年〜2024年）
7.3 ヨーロッパにおける抗体受託製造市場規模、用途別（2019年〜2024年）
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカの抗体受託製造 地域別（2019年～2024年）
8.2 中東・アフリカにおける抗体受託製造市場規模、タイプ別（2019年〜2024年）
8.3 中東・アフリカにおける抗体受託製造市場規模、用途別（2019年〜2024年）
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 グローバルの抗体受託製造市場、市場予測
10.1 グローバルの抗体受託製造、市場予測（地域別）（2025年～2030年）
10.1.1 グローバルの抗体受託製造、市場予測（地域別）（2025年～2030年）
10.1.2 アメリカズの抗体受託製造、市場予測
10.1.3 APACの抗体受託製造、市場予測
10.1.4 ヨーロッパの抗体受託製造、市場予測
10.1.5 中東・アフリカの抗体受託製造、市場予測
10.2 アメリカズの抗体受託製造、市場予測（国別）（2025年～2030年）
10.3 APACの抗体受託製造、市場予測（地域別）（2025年～2030年）
10.4 ヨーロッパの抗体受託製造、市場予測（国別）（2025年～2030年）
10.5 中東・アフリカの抗体受託製造、市場予測（地域別）（2025年～2030年）
10.6 グローバルの抗体受託製造、市場予測（タイプ別）（2025年～2030年）
10.7 グローバルの抗体受託製造、市場予測（用途別）（2025年～2030年）
11 キープレイヤー分析
11.1 AMRI
11.1.1 AMRI：企業情報
11.1.2 AMRI：抗体受託製造分野の提供製品
11.1.3 AMRI：抗体受託製造収益・グロスマージンおよび市場シェア（2019年～2024年）
11.1.4 AMRI：主要事業概要
11.1.5 AMRI：直近の展開
11.2 AGC Biologics
11.2.1 AGC Biologics：企業情報
11.2.2 AGC Biologics：抗体受託製造分野の提供製品
11.2.3 AGC Biologics：抗体受託製造収益・グロスマージンおよび市場シェア（2019年～2024年）
11.2.4 AGC Biologics：主要事業概要
11.2.5 AGC Biologics：直近の展開
11.3 Aldevron
11.3.1 Aldevron：企業情報
11.3.2 Aldevron：抗体受託製造分野の提供製品
11.3.3 Aldevron：抗体受託製造収益・グロスマージンおよび市場シェア（2019年～2024年）
11.3.4 Aldevron：主要事業概要
11.3.5 Aldevron：直近の展開
11.4 Eurofins CDMO
11.4.1 Eurofins CDMO：企業情報
11.4.2 Eurofins CDMO：抗体受託製造分野の提供製品
11.4.3 Eurofins CDMO：抗体受託製造収益・グロスマージンおよび市場シェア（2019年～2024年）
11.4.4 Eurofins CDMO：主要事業概要
11.4.5 Eurofins CDMO：直近の展開
11.5 Boehringer Ingelheim BioXcellence
11.5.1 Boehringer Ingelheim BioXcellence：企業情報
11.5.2 Boehringer Ingelheim BioXcellence：抗体受託製造分野の提供製品
11.5.3 Boehringer Ingelheim BioXcellence：抗体受託製造収益・グロスマージンおよび市場シェア（2019年～2024年）
11.5.4 Boehringer Ingelheim BioXcellence：主要事業概要
11.5.5 Boehringer Ingelheim BioXcellence：直近の展開
11.6 FUJIFILM Diosynth Biotechnologies
11.6.1 FUJIFILM Diosynth Biotechnologies：企業情報
11.6.2 FUJIFILM Diosynth Biotechnologies：抗体受託製造分野の提供製品
11.6.3 FUJIFILM Diosynth Biotechnologies：抗体受託製造収益・グロスマージンおよび市場シェア（2019年～2024年）
11.6.4 FUJIFILM Diosynth Biotechnologies：主要事業概要
11.6.5 FUJIFILM Diosynth Biotechnologies：直近の展開
11.7 Emergent BioSolutions
11.7.1 Emergent BioSolutions：企業情報
11.7.2 Emergent BioSolutions：抗体受託製造分野の提供製品
11.7.3 Emergent BioSolutions：抗体受託製造収益・グロスマージンおよび市場シェア（2019年～2024年）
11.7.4 Emergent BioSolutions：主要事業概要
11.7.5 Emergent BioSolutions：直近の展開
11.8 KBI Biopharma
11.8.1 KBI Biopharma：企業情報
11.8.2 KBI Biopharma：抗体受託製造分野の提供製品
11.8.3 KBI Biopharma：抗体受託製造収益・グロスマージンおよび市場シェア（2019年～2024年）
11.8.4 KBI Biopharma：主要事業概要
11.8.5 KBI Biopharma：直近の展開
11.9 Lonza
11.9.1 Lonza：企業情報
11.9.2 Lonza：抗体受託製造分野の提供製品
11.9.3 Lonza：抗体受託製造収益・グロスマージンおよび市場シェア（2019年～2024年）
11.9.4 Lonza：主要事業概要
11.9.5 Lonza：直近の展開
11.10 Novasep
11.10.1 Novasep：企業情報
11.10.2 Novasep：抗体受託製造分野の提供製品
11.10.3 Novasep：抗体受託製造収益・グロスマージンおよび市場シェア（2019年～2024年）
11.10.4 Novasep：主要事業概要
11.10.5 Novasep：直近の展開
11.11 Nitto Avecia Pharma Services
11.11.1 Nitto Avecia Pharma Services：企業情報
11.11.2 Nitto Avecia Pharma Services：抗体受託製造分野の提供製品
11.11.3 Nitto Avecia Pharma Services：抗体受託製造収益・グロスマージンおよび市場シェア（2019年～2024年）
11.11.4 Nitto Avecia Pharma Services：主要事業概要
11.11.5 Nitto Avecia Pharma Services：直近の展開
11.12 Pierre Fabre
11.12.1 Pierre Fabre：企業情報
11.12.2 Pierre Fabre：抗体受託製造分野の提供製品
11.12.3 Pierre Fabre：抗体受託製造収益・グロスマージンおよび市場シェア（2019年～2024年）
11.12.4 Pierre Fabre：主要事業概要
11.12.5 Pierre Fabre：直近の展開
11.13 Samsung BioLogics
11.13.1 Samsung BioLogics：企業情報
11.13.2 Samsung BioLogics：抗体受託製造分野の提供製品
11.13.3 Samsung BioLogics：抗体受託製造収益・グロスマージンおよび市場シェア（2019年～2024年）
11.13.4 Samsung BioLogics：主要事業概要
11.13.5 Samsung BioLogics：直近の展開
11.14 Synthon
11.14.1 Synthon：企業情報
11.14.2 Synthon：抗体受託製造分野の提供製品
11.14.3 Synthon：抗体受託製造収益・グロスマージンおよび市場シェア（2019年～2024年）
11.14.4 Synthon：主要事業概要
11.14.5 Synthon：直近の展開
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific：企業情報
11.15.2 Thermo Fisher Scientific：抗体受託製造分野の提供製品
11.15.3 Thermo Fisher Scientific：抗体受託製造収益・グロスマージンおよび市場シェア（2019年～2024年）
11.15.4 Thermo Fisher Scientific：主要事業概要
11.15.5 Thermo Fisher Scientific：直近の展開
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
The research report highlights the growth potential of the global Antibodies Contract Manufacturing market. Antibodies Contract Manufacturing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Antibodies Contract Manufacturing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Antibodies Contract Manufacturing market.
Key Features:
The report on Antibodies Contract Manufacturing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Antibodies Contract Manufacturing market. It may include historical data, market segmentation by Type (e.g., Monoclonal Antibodies, Antibody Fragments), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Antibodies Contract Manufacturing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Antibodies Contract Manufacturing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Antibodies Contract Manufacturing industry. This include advancements in Antibodies Contract Manufacturing technology, Antibodies Contract Manufacturing new entrants, Antibodies Contract Manufacturing new investment, and other innovations that are shaping the future of Antibodies Contract Manufacturing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Antibodies Contract Manufacturing market. It includes factors influencing customer ' purchasing decisions, preferences for Antibodies Contract Manufacturing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Antibodies Contract Manufacturing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Antibodies Contract Manufacturing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Antibodies Contract Manufacturing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Antibodies Contract Manufacturing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Antibodies Contract Manufacturing market.
Market Segmentation:
Antibodies Contract Manufacturing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Monoclonal Antibodies
Antibody Fragments
Polyclonal Antibodies
Segmentation by application
SME
Large Enterprise
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AMRI
AGC Biologics
Aldevron
Eurofins CDMO
Boehringer Ingelheim BioXcellence
FUJIFILM Diosynth Biotechnologies
Emergent BioSolutions
KBI Biopharma
Lonza
Novasep
Nitto Avecia Pharma Services
Pierre Fabre
Samsung BioLogics
Synthon
Thermo Fisher Scientific
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antibodies Contract Manufacturing Market Size 2019-2030
2.1.2 Antibodies Contract Manufacturing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Antibodies Contract Manufacturing Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Antibody Fragments
2.2.3 Polyclonal Antibodies
2.3 Antibodies Contract Manufacturing Market Size by Type
2.3.1 Antibodies Contract Manufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Antibodies Contract Manufacturing Market Size Market Share by Type (2019-2024)
2.4 Antibodies Contract Manufacturing Segment by Application
2.4.1 SME
2.4.2 Large Enterprise
2.5 Antibodies Contract Manufacturing Market Size by Application
2.5.1 Antibodies Contract Manufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Antibodies Contract Manufacturing Market Size Market Share by Application (2019-2024)
3 Antibodies Contract Manufacturing Market Size by Player
3.1 Antibodies Contract Manufacturing Market Size Market Share by Players
3.1.1 Global Antibodies Contract Manufacturing Revenue by Players (2019-2024)
3.1.2 Global Antibodies Contract Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Antibodies Contract Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Antibodies Contract Manufacturing by Regions
4.1 Antibodies Contract Manufacturing Market Size by Regions (2019-2024)
4.2 Americas Antibodies Contract Manufacturing Market Size Growth (2019-2024)
4.3 APAC Antibodies Contract Manufacturing Market Size Growth (2019-2024)
4.4 Europe Antibodies Contract Manufacturing Market Size Growth (2019-2024)
4.5 Middle East & Africa Antibodies Contract Manufacturing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Antibodies Contract Manufacturing Market Size by Country (2019-2024)
5.2 Americas Antibodies Contract Manufacturing Market Size by Type (2019-2024)
5.3 Americas Antibodies Contract Manufacturing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibodies Contract Manufacturing Market Size by Region (2019-2024)
6.2 APAC Antibodies Contract Manufacturing Market Size by Type (2019-2024)
6.3 APAC Antibodies Contract Manufacturing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Antibodies Contract Manufacturing by Country (2019-2024)
7.2 Europe Antibodies Contract Manufacturing Market Size by Type (2019-2024)
7.3 Europe Antibodies Contract Manufacturing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antibodies Contract Manufacturing by Region (2019-2024)
8.2 Middle East & Africa Antibodies Contract Manufacturing Market Size by Type (2019-2024)
8.3 Middle East & Africa Antibodies Contract Manufacturing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Antibodies Contract Manufacturing Market Forecast
10.1 Global Antibodies Contract Manufacturing Forecast by Regions (2025-2030)
10.1.1 Global Antibodies Contract Manufacturing Forecast by Regions (2025-2030)
10.1.2 Americas Antibodies Contract Manufacturing Forecast
10.1.3 APAC Antibodies Contract Manufacturing Forecast
10.1.4 Europe Antibodies Contract Manufacturing Forecast
10.1.5 Middle East & Africa Antibodies Contract Manufacturing Forecast
10.2 Americas Antibodies Contract Manufacturing Forecast by Country (2025-2030)
10.2.1 United States Antibodies Contract Manufacturing Market Forecast
10.2.2 Canada Antibodies Contract Manufacturing Market Forecast
10.2.3 Mexico Antibodies Contract Manufacturing Market Forecast
10.2.4 Brazil Antibodies Contract Manufacturing Market Forecast
10.3 APAC Antibodies Contract Manufacturing Forecast by Region (2025-2030)
10.3.1 China Antibodies Contract Manufacturing Market Forecast
10.3.2 Japan Antibodies Contract Manufacturing Market Forecast
10.3.3 Korea Antibodies Contract Manufacturing Market Forecast
10.3.4 Southeast Asia Antibodies Contract Manufacturing Market Forecast
10.3.5 India Antibodies Contract Manufacturing Market Forecast
10.3.6 Australia Antibodies Contract Manufacturing Market Forecast
10.4 Europe Antibodies Contract Manufacturing Forecast by Country (2025-2030)
10.4.1 Germany Antibodies Contract Manufacturing Market Forecast
10.4.2 France Antibodies Contract Manufacturing Market Forecast
10.4.3 UK Antibodies Contract Manufacturing Market Forecast
10.4.4 Italy Antibodies Contract Manufacturing Market Forecast
10.4.5 Russia Antibodies Contract Manufacturing Market Forecast
10.5 Middle East & Africa Antibodies Contract Manufacturing Forecast by Region (2025-2030)
10.5.1 Egypt Antibodies Contract Manufacturing Market Forecast
10.5.2 South Africa Antibodies Contract Manufacturing Market Forecast
10.5.3 Israel Antibodies Contract Manufacturing Market Forecast
10.5.4 Turkey Antibodies Contract Manufacturing Market Forecast
10.5.5 GCC Countries Antibodies Contract Manufacturing Market Forecast
10.6 Global Antibodies Contract Manufacturing Forecast by Type (2025-2030)
10.7 Global Antibodies Contract Manufacturing Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 AMRI
11.1.1 AMRI Company Information
11.1.2 AMRI Antibodies Contract Manufacturing Product Offered
11.1.3 AMRI Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AMRI Main Business Overview
11.1.5 AMRI Latest Developments
11.2 AGC Biologics
11.2.1 AGC Biologics Company Information
11.2.2 AGC Biologics Antibodies Contract Manufacturing Product Offered
11.2.3 AGC Biologics Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AGC Biologics Main Business Overview
11.2.5 AGC Biologics Latest Developments
11.3 Aldevron
11.3.1 Aldevron Company Information
11.3.2 Aldevron Antibodies Contract Manufacturing Product Offered
11.3.3 Aldevron Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Aldevron Main Business Overview
11.3.5 Aldevron Latest Developments
11.4 Eurofins CDMO
11.4.1 Eurofins CDMO Company Information
11.4.2 Eurofins CDMO Antibodies Contract Manufacturing Product Offered
11.4.3 Eurofins CDMO Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Eurofins CDMO Main Business Overview
11.4.5 Eurofins CDMO Latest Developments
11.5 Boehringer Ingelheim BioXcellence
11.5.1 Boehringer Ingelheim BioXcellence Company Information
11.5.2 Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Product Offered
11.5.3 Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Boehringer Ingelheim BioXcellence Main Business Overview
11.5.5 Boehringer Ingelheim BioXcellence Latest Developments
11.6 FUJIFILM Diosynth Biotechnologies
11.6.1 FUJIFILM Diosynth Biotechnologies Company Information
11.6.2 FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Product Offered
11.6.3 FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.6.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.7 Emergent BioSolutions
11.7.1 Emergent BioSolutions Company Information
11.7.2 Emergent BioSolutions Antibodies Contract Manufacturing Product Offered
11.7.3 Emergent BioSolutions Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Emergent BioSolutions Main Business Overview
11.7.5 Emergent BioSolutions Latest Developments
11.8 KBI Biopharma
11.8.1 KBI Biopharma Company Information
11.8.2 KBI Biopharma Antibodies Contract Manufacturing Product Offered
11.8.3 KBI Biopharma Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 KBI Biopharma Main Business Overview
11.8.5 KBI Biopharma Latest Developments
11.9 Lonza
11.9.1 Lonza Company Information
11.9.2 Lonza Antibodies Contract Manufacturing Product Offered
11.9.3 Lonza Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Lonza Main Business Overview
11.9.5 Lonza Latest Developments
11.10 Novasep
11.10.1 Novasep Company Information
11.10.2 Novasep Antibodies Contract Manufacturing Product Offered
11.10.3 Novasep Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Novasep Main Business Overview
11.10.5 Novasep Latest Developments
11.11 Nitto Avecia Pharma Services
11.11.1 Nitto Avecia Pharma Services Company Information
11.11.2 Nitto Avecia Pharma Services Antibodies Contract Manufacturing Product Offered
11.11.3 Nitto Avecia Pharma Services Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Nitto Avecia Pharma Services Main Business Overview
11.11.5 Nitto Avecia Pharma Services Latest Developments
11.12 Pierre Fabre
11.12.1 Pierre Fabre Company Information
11.12.2 Pierre Fabre Antibodies Contract Manufacturing Product Offered
11.12.3 Pierre Fabre Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Pierre Fabre Main Business Overview
11.12.5 Pierre Fabre Latest Developments
11.13 Samsung BioLogics
11.13.1 Samsung BioLogics Company Information
11.13.2 Samsung BioLogics Antibodies Contract Manufacturing Product Offered
11.13.3 Samsung BioLogics Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Samsung BioLogics Main Business Overview
11.13.5 Samsung BioLogics Latest Developments
11.14 Synthon
11.14.1 Synthon Company Information
11.14.2 Synthon Antibodies Contract Manufacturing Product Offered
11.14.3 Synthon Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Synthon Main Business Overview
11.14.5 Synthon Latest Developments
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Information
11.15.2 Thermo Fisher Scientific Antibodies Contract Manufacturing Product Offered
11.15.3 Thermo Fisher Scientific Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Thermo Fisher Scientific Main Business Overview
11.15.5 Thermo Fisher Scientific Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Antibodies Contract Manufacturing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions) Table 2. Major Players of Monoclonal Antibodies Table 3. Major Players of Antibody Fragments Table 4. Major Players of Polyclonal Antibodies Table 5. Antibodies Contract Manufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions) Table 6. Global Antibodies Contract Manufacturing Market Size by Type (2019-2024) & ($ Millions) Table 7. Global Antibodies Contract Manufacturing Market Size Market Share by Type (2019-2024) Table 8. Antibodies Contract Manufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions) Table 9. Global Antibodies Contract Manufacturing Market Size by Application (2019-2024) & ($ Millions) Table 10. Global Antibodies Contract Manufacturing Market Size Market Share by Application (2019-2024) Table 11. Global Antibodies Contract Manufacturing Revenue by Players (2019-2024) & ($ Millions) Table 12. Global Antibodies Contract Manufacturing Revenue Market Share by Player (2019-2024) Table 13. Antibodies Contract Manufacturing Key Players Head office and Products Offered Table 14. Antibodies Contract Manufacturing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) Table 15. New Products and Potential Entrants Table 16. Mergers & Acquisitions, Expansion Table 17. Global Antibodies Contract Manufacturing Market Size by Regions 2019-2024 & ($ Millions) Table 18. Global Antibodies Contract Manufacturing Market Size Market Share by Regions (2019-2024) Table 19. Global Antibodies Contract Manufacturing Revenue by Country/Region (2019-2024) & ($ millions) Table 20. Global Antibodies Contract Manufacturing Revenue Market Share by Country/Region (2019-2024) Table 21. Americas Antibodies Contract Manufacturing Market Size by Country (2019-2024) & ($ Millions) Table 22. Americas Antibodies Contract Manufacturing Market Size Market Share by Country (2019-2024) Table 23. Americas Antibodies Contract Manufacturing Market Size by Type (2019-2024) & ($ Millions) Table 24. Americas Antibodies Contract Manufacturing Market Size Market Share by Type (2019-2024) Table 25. Americas Antibodies Contract Manufacturing Market Size by Application (2019-2024) & ($ Millions) Table 26. Americas Antibodies Contract Manufacturing Market Size Market Share by Application (2019-2024) Table 27. APAC Antibodies Contract Manufacturing Market Size by Region (2019-2024) & ($ Millions) Table 28. APAC Antibodies Contract Manufacturing Market Size Market Share by Region (2019-2024) Table 29. APAC Antibodies Contract Manufacturing Market Size by Type (2019-2024) & ($ Millions) Table 30. APAC Antibodies Contract Manufacturing Market Size Market Share by Type (2019-2024) Table 31. APAC Antibodies Contract Manufacturing Market Size by Application (2019-2024) & ($ Millions) Table 32. APAC Antibodies Contract Manufacturing Market Size Market Share by Application (2019-2024) Table 33. Europe Antibodies Contract Manufacturing Market Size by Country (2019-2024) & ($ Millions) Table 34. Europe Antibodies Contract Manufacturing Market Size Market Share by Country (2019-2024) Table 35. Europe Antibodies Contract Manufacturing Market Size by Type (2019-2024) & ($ Millions) Table 36. Europe Antibodies Contract Manufacturing Market Size Market Share by Type (2019-2024) Table 37. Europe Antibodies Contract Manufacturing Market Size by Application (2019-2024) & ($ Millions) Table 38. Europe Antibodies Contract Manufacturing Market Size Market Share by Application (2019-2024) Table 39. Middle East & Africa Antibodies Contract Manufacturing Market Size by Region (2019-2024) & ($ Millions) Table 40. Middle East & Africa Antibodies Contract Manufacturing Market Size Market Share by Region (2019-2024) Table 41. Middle East & Africa Antibodies Contract Manufacturing Market Size by Type (2019-2024) & ($ Millions) Table 42. Middle East & Africa Antibodies Contract Manufacturing Market Size Market Share by Type (2019-2024) Table 43. Middle East & Africa Antibodies Contract Manufacturing Market Size by Application (2019-2024) & ($ Millions) Table 44. Middle East & Africa Antibodies Contract Manufacturing Market Size Market Share by Application (2019-2024) Table 45. Key Market Drivers & Growth Opportunities of Antibodies Contract Manufacturing Table 46. Key Market Challenges & Risks of Antibodies Contract Manufacturing Table 47. Key Industry Trends of Antibodies Contract Manufacturing Table 48. Global Antibodies Contract Manufacturing Market Size Forecast by Regions (2025-2030) & ($ Millions) Table 49. Global Antibodies Contract Manufacturing Market Size Market Share Forecast by Regions (2025-2030) Table 50. Global Antibodies Contract Manufacturing Market Size Forecast by Type (2025-2030) & ($ Millions) Table 51. Global Antibodies Contract Manufacturing Market Size Forecast by Application (2025-2030) & ($ Millions) Table 52. AMRI Details, Company Type, Antibodies Contract Manufacturing Area Served and Its Competitors Table 53. AMRI Antibodies Contract Manufacturing Product Offered Table 54. AMRI Antibodies Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 55. AMRI Main Business Table 56. AMRI Latest Developments Table 57. AGC Biologics Details, Company Type, Antibodies Contract Manufacturing Area Served and Its Competitors Table 58. AGC Biologics Antibodies Contract Manufacturing Product Offered Table 59. AGC Biologics Main Business Table 60. AGC Biologics Antibodies Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 61. AGC Biologics Latest Developments Table 62. Aldevron Details, Company Type, Antibodies Contract Manufacturing Area Served and Its Competitors Table 63. Aldevron Antibodies Contract Manufacturing Product Offered Table 64. Aldevron Main Business Table 65. Aldevron Antibodies Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 66. Aldevron Latest Developments Table 67. Eurofins CDMO Details, Company Type, Antibodies Contract Manufacturing Area Served and Its Competitors Table 68. Eurofins CDMO Antibodies Contract Manufacturing Product Offered Table 69. Eurofins CDMO Main Business Table 70. Eurofins CDMO Antibodies Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 71. Eurofins CDMO Latest Developments Table 72. Boehringer Ingelheim BioXcellence Details, Company Type, Antibodies Contract Manufacturing Area Served and Its Competitors Table 73. Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Product Offered Table 74. Boehringer Ingelheim BioXcellence Main Business Table 75. Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 76. Boehringer Ingelheim BioXcellence Latest Developments Table 77. FUJIFILM Diosynth Biotechnologies Details, Company Type, Antibodies Contract Manufacturing Area Served and Its Competitors Table 78. FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Product Offered Table 79. FUJIFILM Diosynth Biotechnologies Main Business Table 80. FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 81. FUJIFILM Diosynth Biotechnologies Latest Developments Table 82. Emergent BioSolutions Details, Company Type, Antibodies Contract Manufacturing Area Served and Its Competitors Table 83. Emergent BioSolutions Antibodies Contract Manufacturing Product Offered Table 84. Emergent BioSolutions Main Business Table 85. Emergent BioSolutions Antibodies Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 86. Emergent BioSolutions Latest Developments Table 87. KBI Biopharma Details, Company Type, Antibodies Contract Manufacturing Area Served and Its Competitors Table 88. KBI Biopharma Antibodies Contract Manufacturing Product Offered Table 89. KBI Biopharma Main Business Table 90. KBI Biopharma Antibodies Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 91. KBI Biopharma Latest Developments Table 92. Lonza Details, Company Type, Antibodies Contract Manufacturing Area Served and Its Competitors Table 93. Lonza Antibodies Contract Manufacturing Product Offered Table 94. Lonza Main Business Table 95. Lonza Antibodies Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 96. Lonza Latest Developments Table 97. Novasep Details, Company Type, Antibodies Contract Manufacturing Area Served and Its Competitors Table 98. Novasep Antibodies Contract Manufacturing Product Offered Table 99. Novasep Main Business Table 100. Novasep Antibodies Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 101. Novasep Latest Developments Table 102. Nitto Avecia Pharma Services Details, Company Type, Antibodies Contract Manufacturing Area Served and Its Competitors Table 103. Nitto Avecia Pharma Services Antibodies Contract Manufacturing Product Offered Table 104. Nitto Avecia Pharma Services Antibodies Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 105. Nitto Avecia Pharma Services Main Business Table 106. Nitto Avecia Pharma Services Latest Developments Table 107. Pierre Fabre Details, Company Type, Antibodies Contract Manufacturing Area Served and Its Competitors Table 108. Pierre Fabre Antibodies Contract Manufacturing Product Offered Table 109. Pierre Fabre Main Business Table 110. Pierre Fabre Antibodies Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 111. Pierre Fabre Latest Developments Table 112. Samsung BioLogics Details, Company Type, Antibodies Contract Manufacturing Area Served and Its Competitors Table 113. Samsung BioLogics Antibodies Contract Manufacturing Product Offered Table 114. Samsung BioLogics Main Business Table 115. Samsung BioLogics Antibodies Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 116. Samsung BioLogics Latest Developments Table 117. Synthon Details, Company Type, Antibodies Contract Manufacturing Area Served and Its Competitors Table 118. Synthon Antibodies Contract Manufacturing Product Offered Table 119. Synthon Main Business Table 120. Synthon Antibodies Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 121. Synthon Latest Developments Table 122. Thermo Fisher Scientific Details, Company Type, Antibodies Contract Manufacturing Area Served and Its Competitors Table 123. Thermo Fisher Scientific Antibodies Contract Manufacturing Product Offered Table 124. Thermo Fisher Scientific Main Business Table 125. Thermo Fisher Scientific Antibodies Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 126. Thermo Fisher Scientific Latest Developments List of Figures Figure 1. Antibodies Contract Manufacturing Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Antibodies Contract Manufacturing Market Size Growth Rate 2019-2030 ($ Millions) Figure 6. Antibodies Contract Manufacturing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 7. Antibodies Contract Manufacturing Sales Market Share by Country/Region (2023) Figure 8. Antibodies Contract Manufacturing Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 9. Global Antibodies Contract Manufacturing Market Size Market Share by Type in 2023 Figure 10. Antibodies Contract Manufacturing in SME Figure 11. Global Antibodies Contract Manufacturing Market: SME (2019-2024) & ($ Millions) Figure 12. Antibodies Contract Manufacturing in Large Enterprise Figure 13. Global Antibodies Contract Manufacturing Market: Large Enterprise (2019-2024) & ($ Millions) Figure 14. Global Antibodies Contract Manufacturing Market Size Market Share by Application in 2023 Figure 15. Global Antibodies Contract Manufacturing Revenue Market Share by Player in 2023 Figure 16. Global Antibodies Contract Manufacturing Market Size Market Share by Regions (2019-2024) Figure 17. Americas Antibodies Contract Manufacturing Market Size 2019-2024 ($ Millions) Figure 18. APAC Antibodies Contract Manufacturing Market Size 2019-2024 ($ Millions) Figure 19. Europe Antibodies Contract Manufacturing Market Size 2019-2024 ($ Millions) Figure 20. Middle East & Africa Antibodies Contract Manufacturing Market Size 2019-2024 ($ Millions) Figure 21. Americas Antibodies Contract Manufacturing Value Market Share by Country in 2023 Figure 22. United States Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 23. Canada Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 24. Mexico Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 25. Brazil Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 26. APAC Antibodies Contract Manufacturing Market Size Market Share by Region in 2023 Figure 27. APAC Antibodies Contract Manufacturing Market Size Market Share by Type in 2023 Figure 28. APAC Antibodies Contract Manufacturing Market Size Market Share by Application in 2023 Figure 29. China Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 30. Japan Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 31. Korea Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 32. Southeast Asia Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 33. India Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 34. Australia Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 35. Europe Antibodies Contract Manufacturing Market Size Market Share by Country in 2023 Figure 36. Europe Antibodies Contract Manufacturing Market Size Market Share by Type (2019-2024) Figure 37. Europe Antibodies Contract Manufacturing Market Size Market Share by Application (2019-2024) Figure 38. Germany Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 39. France Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 40. UK Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 41. Italy Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 42. Russia Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 43. Middle East & Africa Antibodies Contract Manufacturing Market Size Market Share by Region (2019-2024) Figure 44. Middle East & Africa Antibodies Contract Manufacturing Market Size Market Share by Type (2019-2024) Figure 45. Middle East & Africa Antibodies Contract Manufacturing Market Size Market Share by Application (2019-2024) Figure 46. Egypt Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 47. South Africa Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 48. Israel Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 49. Turkey Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 50. GCC Country Antibodies Contract Manufacturing Market Size Growth 2019-2024 ($ Millions) Figure 51. Americas Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 52. APAC Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 53. Europe Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 54. Middle East & Africa Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 55. United States Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 56. Canada Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 57. Mexico Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 58. Brazil Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 59. China Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 60. Japan Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 61. Korea Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 62. Southeast Asia Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 63. India Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 64. Australia Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 65. Germany Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 66. France Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 67. UK Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 68. Italy Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 69. Russia Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 70. Spain Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 71. Egypt Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 72. South Africa Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 73. Israel Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 74. Turkey Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 75. GCC Countries Antibodies Contract Manufacturing Market Size 2025-2030 ($ Millions) Figure 76. Global Antibodies Contract Manufacturing Market Size Market Share Forecast by Type (2025-2030) Figure 77. Global Antibodies Contract Manufacturing Market Size Market Share Forecast by Application (2025-2030)
